Progressive agrammatic aphasia without apraxia of speech as a distinct syndrome.


Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
01 08 2019
Historique:
received: 29 11 2018
revised: 09 04 2019
accepted: 16 04 2019
pubmed: 15 6 2019
medline: 27 5 2020
entrez: 15 6 2019
Statut: ppublish

Résumé

Agrammatic aphasia affects grammatical language production and can result from a neurodegenerative disease. Although it typically presents with concomitant apraxia of speech, this is not always the case. Little is known about the clinical course and imaging features of patients that present with agrammatism in the absence of apraxia of speech, which we will refer to as progressive agrammatic aphasia. We aimed to make a detailed description of the longitudinal clinical, linguistic, and neuroimaging features of a cohort of 11 patients with progressive agrammatic aphasia to provide a complete picture of this syndrome. All patients underwent detailed speech and language, neurological and neuropsychological assessments, 3 T structural and diffusion tensor imaging MRI, 18F-fluorodeoxyglucose and Pittsburgh compound B PET. The 11 patients were matched by age and gender to 22 patients who had mixed apraxia of speech and agrammatism. The progressive agrammatic aphasia patients performed abnormally on tests of language, general cognition, executive function, and functional ability at baseline and declined in these measures over time. Only two patients eventually developed apraxia of speech, while parkinsonism was absent-to-mild throughout all visits for all patients. When compared to the patients with mixed apraxia of speech and agrammatism, the patients with progressive agrammatic aphasia performed better on tests of motor speech and parkinsonism but more poorly, and declined faster over time, on tests of general aphasia severity, agrammatism, and naming. The patients with progressive agrammatic aphasia also showed different neuroimaging abnormalities, with greater atrophy, hypometabolism and white matter tract degeneration in the prefrontal and anterior temporal lobes compared to patients with mixed apraxia of speech and agrammatism. These differences were more pronounced as the disease progressed. These results demonstrate that progressive agrammatic aphasia has a different clinical disease course and different underlying neuroanatomical abnormalities than patients with the more common syndrome of mixed agrammatism and apraxia of speech. This supports the distinction of progressive agrammatic aphasia and has implications for the classification of patients with agrammatic aphasia.

Identifiants

pubmed: 31199471
pii: 5519088
doi: 10.1093/brain/awz157
pmc: PMC6658844
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2466-2482

Subventions

Organisme : NIDCD NIH HHS
ID : R01 DC014942
Pays : United States
Organisme : NIDCD NIH HHS
ID : R01 DC012519
Pays : United States
Organisme : NIDCD NIH HHS
ID : R01 DC010367
Pays : United States
Organisme : NINDS NIH HHS
ID : R21 NS094684
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG006786
Pays : United States

Informations de copyright

© The Author(s) (2019). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Références

J Neuropsychiatry Clin Neurosci. 2000 Spring;12(2):233-9
pubmed: 11001602
Neurology. 2000 Dec 12;55(11):1621-6
pubmed: 11113214
Neurology. 2002 Jan 22;58(2):198-208
pubmed: 11805245
Brain. 1962 Dec;85:665-78
pubmed: 14026018
Arch Clin Neuropsychol. 1999 Aug;14(6):481-7
pubmed: 14590575
Ann Neurol. 2004 Mar;55(3):335-46
pubmed: 14991811
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Neuroimage. 2005 Jul 1;26(3):839-51
pubmed: 15955494
Neurocase. 2005 Aug;11(4):283-96
pubmed: 16093229
Brain. 2006 Jun;129(Pt 6):1385-98
pubmed: 16613895
Alzheimer Dis Assoc Disord. 2007 Oct-Dec;21(4):S14-8
pubmed: 18090417
Alzheimer Dis Assoc Disord. 2007 Oct-Dec;21(4):S23-30
pubmed: 18090419
Mov Disord. 2008 Nov 15;23(15):2129-70
pubmed: 19025984
J Magn Reson. 2009 Apr;197(2):108-19
pubmed: 19138540
J Neurol. 2009 Mar;256(3):382-9
pubmed: 19271103
Am J Alzheimers Dis Other Demen. 2009 Oct-Nov;24(5):408-16
pubmed: 19700669
J Neurolinguistics. 2008 Sep;21(5):418-432
pubmed: 19727332
Neuroimage. 2010 Feb 1;49(3):2457-66
pubmed: 19818860
Neurology. 2010 Jan 5;74(1):42-9
pubmed: 19940270
Brain Lang. 2010 Apr;113(1):13-20
pubmed: 20074786
Neurology. 2010 Apr 20;74(16):1279-87
pubmed: 20404309
Brain. 2010 Jul;133(Pt 7):2069-88
pubmed: 20542982
Brain. 2011 Feb;134(Pt 2):405-14
pubmed: 20959310
Neurology. 2011 Mar 15;76(11):1006-14
pubmed: 21325651
Front Syst Neurosci. 2011 Feb 10;5:1
pubmed: 21347218
Alzheimers Dement. 2011 May;7(3):263-9
pubmed: 21514250
Neurology. 2011 May 24;76(21):1804-10
pubmed: 21606451
Curr Neurol Neurosci Rep. 2011 Dec;11(6):553-9
pubmed: 21853238
Brain. 2012 May;135(Pt 5):1522-36
pubmed: 22382356
Neurobiol Aging. 2013 Feb;34(2):636-9
pubmed: 22502999
J Speech Lang Hear Res. 2012 Oct;55(5):S1562-72
pubmed: 23033449
Curr Opin Neurobiol. 2013 Apr;23(2):250-4
pubmed: 23146876
J Neurol. 2013 Jun;260(6):1594-600
pubmed: 23358624
Neurology. 2013 Jan 29;80(5):496-503
pubmed: 23359374
Brain Lang. 2013 Jun;125(3):245-52
pubmed: 23542727
Neurology. 2013 Jul 23;81(4):337-45
pubmed: 23803320
Neurology. 1990 Aug;40(8):1203-12
pubmed: 2381527
Brain. 2013 Aug;136(Pt 8):2619-28
pubmed: 23820597
J Cogn Neurosci. 1996 Spring;8(2):135-54
pubmed: 23971420
Neurology. 2013 Nov 19;81(21):1832-9
pubmed: 24142474
Front Neuroinform. 2014 Feb 21;8:8
pubmed: 24600385
Neuroimage. 2014 Jul 1;94:65-78
pubmed: 24650605
Neurology. 2014 May 13;82(19):1729-35
pubmed: 24727315
J Commun Disord. 2014 Sep-Oct;51:43-50
pubmed: 25092638
Neurology. 2014 Sep 23;83(13):1184-91
pubmed: 25165386
Aphasiology. 2014 Sep;28(8-9):1018-1037
pubmed: 25642014
Neuroimage. 2015 Jun;113:61-9
pubmed: 25797830
J Int Neuropsychol Soc. 2015 Jul;21(6):429-35
pubmed: 26067425
Cortex. 2015 Aug;69:220-36
pubmed: 26103600
Neuroimage. 2016 Jan 15;125:1063-1078
pubmed: 26481672
Neuropsychologia. 2016 Jan 29;81:129-139
pubmed: 26707715
Magn Reson Med. 2016 Nov;76(5):1574-1581
pubmed: 26745823
JAMA Neurol. 2016 Jun 1;73(6):733-42
pubmed: 27111692
Neuroimage. 2016 Nov 15;142:394-406
pubmed: 27523449
Alzheimers Dement. 2017 Mar;13(3):205-216
pubmed: 27697430
Mov Disord. 2017 Jun;32(6):853-864
pubmed: 28467028
Neurology. 2017 Jul 4;89(1):88-100
pubmed: 28592453
Brain. 2018 Jan 1;141(1):302-317
pubmed: 29228180
J Speech Lang Hear Res. 2018 Sep 19;61(9):2337-2346
pubmed: 30098169
J Nucl Med. 1995 Jul;36(7):1238-48
pubmed: 7790950
Neurology. 1993 Nov;43(11):2412-4
pubmed: 8232972
Can J Neurol Sci. 1997 Feb;24(1):29-36
pubmed: 9043744

Auteurs

Katerina A Tetzloff (KA)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Joseph R Duffy (JR)

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Heather M Clark (HM)

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Rene L Utianski (RL)

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Edythe A Strand (EA)

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Mary M Machulda (MM)

Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.

Hugo Botha (H)

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Peter R Martin (PR)

Department of Health Sciences Research (Biostatistics), Mayo Clinic, Rochester, MN, USA.

Christopher G Schwarz (CG)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Matthew L Senjem (ML)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Robert I Reid (RI)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Jeffrey L Gunter (JL)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Anthony J Spychalla (AJ)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

David S Knopman (DS)

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Ronald C Petersen (RC)

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Clifford R Jack (CR)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Val J Lowe (VJ)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Keith A Josephs (KA)

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Jennifer L Whitwell (JL)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH